ACT on Asthma Programme: A Collaboration between Rowlands Pharmacy and GSK
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: DAVIES, James (UCL School of Pharmacy, Department of Practice and Policy, London, United Kingdom)
- Co-author(s): Gill, Jennifer (UCL School of Pharmacy, London, United Kingdom)
Taylor, David (UCL School of Pharmacy, London, United Kingdom)
Grundy, Nicky (Rowlands Pharmacy, Runcorn, United Kingdom)
Campbell, Eilidh (Rowlands Pharmacy, Runcorn, United Kingdom)
Ibberson, Andrew (GlaxoSmithKline, Brentford, London, United Kingdom)
Background: Asthma, a chronic inflammatory disease of the airways, afflicts 4.3 million adults in the UK. The average community pharmacy in the UK supports about 400 asthmatic patients in the use of inhaled medicines and plays a key role in improving both the use and understanding of asthma medications.
Aim: To improve the health and optimise the .. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.